Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
KMTS
vs
S&P 500
S&P 500
Over the past 12 months, KMTS has underperformed S&P 500, delivering a return of +15% compared to S&P 500's +16% growth.
Stocks Performance
KMTS vs S&P 500
Performance Gap
KMTS vs S&P 500
Performance By Year
KMTS vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Kestra Medical Technologies Ltd
Glance View
Kestra Medical Technologies makes wearable medical devices for patients at risk of dangerous heart rhythm problems. Its main products are designed to monitor the heart outside the hospital and deliver treatment if a life-threatening rhythm is detected. The company sells these devices as part of a medical system that helps doctors manage patients who need protection after a cardiac event or while they are being evaluated for longer-term care. Its customers are mainly hospitals, cardiologists, electrophysiologists, and other heart specialists who prescribe the device for patients. Kestra makes money by selling or leasing its equipment and by earning recurring revenue tied to device use, monitoring, and related services, depending on the customer arrangement. The business sits between hospitals and patients, turning a complex medical need into a service that can be used at home. What makes the business model distinct is that it combines hardware, software, and clinical support in one product category. Unlike a simple medical device sale, the value comes from the whole system: sensing heart rhythms, alerting clinicians, and treating a serious event when needed. That makes Kestra part of the cardiac care chain rather than a broad hospital supplier.